[Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
Introduction of HAART in the treatment of HIV-infection revealed, that clinical consequences of HIV-infection in these patients occur earlier than in HIV-negative ones. It may be a reason of unsuccessfully antiretroviral therapy. Another problem is hepatotoxicity of antiretroviral therapy, especially in HCV-infected patients. In the follow, treatment of chronic hepatitis C seems to be justified.